- Predicting Pathological Complete Response in Breast Cancer After Two Cycles of Neoadjuvant Chemotherapy by Tumor Reduction Rate: A Retrospective Case-Control Study
-
Yao L, Liu X, Wang M, Yu K, Xu S, Qiu P, Lv Z, Zhang X, Xu Y
- KMID: 2541764
- J Breast Cancer.
- 2023 Apr;26(2):136-151.
- doi: 10.4048/jbc.2023.26.e12
Purpose: We aimed to identify effectiveness-associated indicators and evaluate the optimal tumor reduction rate (TRR) after two cycles of neoadjuvant chemotherapy (NAC) in patients with invasive breast cancer. Methods: This retrospective... -
- CITED
-
- Close
- SHARE
-
- Close
- Internal Mammary Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer
-
Bi Z, Chen P, Liu J, Liu Y, Qiu P, Yang Q, Zheng W, Wang Y
- KMID: 2429823
- J Breast Cancer.
- 2018 Dec;21(4):442-446.
- doi: 10.4048/jbc.2018.21.e49
PURPOSE: The definition of nodal pathologic complete response (pCR) after a neoadjuvant chemotherapy (NAC) just included the evaluation of axillary lymph node (ALN) without internal mammary lymph node. This study... -
- CITED
-
- Close
- SHARE
-
- Close
- Murine Model Study of a New Receptor-Targeted Tracer for Sentinel Lymph Node in Breast Cancer
-
Tian C, Sun X, Cong B, Qiu P, Wang Y
- KMID: 2450121
- J Breast Cancer.
- 2019 Jun;22(2):274-284.
- doi: 10.4048/jbc.2019.22.e28
PURPOSE: Sentinel lymph node biopsy (SLNB), a critical staging and treatment step, has replaced axillary lymph node (LN) dissection as the standard staging procedure for early stage breast cancer patients... -
- CITED
-
- Close
- SHARE
-
- Close
